[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
βπ ΎοΈβοΈπ£ posts on X about $azn, $991m, $pfe, unlock the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks finance currencies cryptocurrencies
Social topic influence $azn #132, $991m, $pfe, unlock, $43b, pfe, top1, $dsnky, novartis, $rog
Top assets mentioned AstraZeneca PLC (AZN) Pfizer, Inc. (PFE) Novartis AG (NVS) ROGin AI (ROG) Merck & Co., Inc. (MRK) Eli Lilly and Company (LLY)
Top posts by engagements in the last XX hours
"Boehringer Ingelheim advances ADC portfolio with an Exatecan-based ADC (AMB304) from AimedBio worth up to $991M. AMB304 is a preclinical asset. AimedBio have one asset in Phase X. #AVCT"
X Link @tom_the_bomb__ 2025-10-15T16:48Z 3305 followers, 3738 engagements
"I wonder what BP is saying about #AVCTs preCISION platform Pfizer: Buy once unlock Seagens entire ADC portfolio & finally dose TOP1 payloads without hitting toxicity walls. Turns a $43B Seagen buy into a platform that actually reaches its potential. 1/4 #AVCT $PFE"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3304 followers, 3150 engagements
"AstraZeneca: Integrate preCISION to extend #Enhertus reach significantly improve dosing potential & move TOP1 chemistry into new tumour types. Frees them from dependency on $DSNKY and creates a next-gen deruxtecan. 2/4 #AVCT $AZN #AZN"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 1795 engagements
"@TBSfrench @AndrewDigby3 Not a shit week RH and his investors moved the SP north by fading the shadow of no cash Are you implying theres another placing on the way"
X Link @tom_the_bomb__ 2025-10-17T21:22Z 3305 followers, XX engagements
"@SeanDentBsc @TragedyCalls So which will it be. Partnerships then a buyout makes the most sense (and definitely my preference before 6103 data)"
X Link @tom_the_bomb__ 2025-10-16T11:51Z 3305 followers, XXX engagements
"@JStonker They stuck Novartis at the bottom & Avacta at the top next to AZN. π #AVCT is an "Unmissable event highlight" alongside Roche $ROG and AstraZeneca #AZN $AZN. @avacta has a LOT of industry eyes on their patented preCISION tech"
X Link @tom_the_bomb__ 2025-09-02T14:08Z 3301 followers, XXX engagements
"@AndrewDigby3 @asininitybeyond Pfizer. Even better. #Fight"
X Link @tom_the_bomb__ 2025-10-14T14:17Z 3301 followers, XXX engagements
"Just added more #AVCT & #MKA to my SIPP. Two companies that I believe will have a great Q4 2025 & more broadly throughout 2026. I added to #GGP last week too. #LetsGo DYOR"
X Link @tom_the_bomb__ 2025-10-09T07:11Z 3302 followers, 5565 engagements
""FAP-Dox and FAP-EXd are only the tip of the preCISION iceberg" Under the surface: "preCISION molecules in stages of preclinical testing and prep work for the clinic. Multiple therapeutic classes (n10)" Likely 11-15+ molecules across multiple therapeutic classes. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T11:36Z 3305 followers, 2510 engagements
"@AndrewDigby3 @asininitybeyond The CSO has worked at AstraZeneca"
X Link @tom_the_bomb__ 2025-10-14T14:34Z 3300 followers, XXX engagements
"@asininitybeyond BIG update/insight from TD (IMO). A ATR or PARP inhibitor sits with the recent comments on an incoming pathway inhibitor deal. Few BP have both of these drug classes apart from AstraZeneca. #AVCT's dual-payload linker would solve AZs biggest limitation = overlapping toxicity"
X Link @tom_the_bomb__ 2025-10-14T14:12Z 3304 followers, 1706 engagements
"@asininitybeyond @Towlie1981 @PJ_Crabb AI's view below. #AVCT"
X Link @tom_the_bomb__ 2025-10-13T08:39Z 3304 followers, 1964 engagements
"Merck: Combine tumour-activated chemo with #Keytruda to deliver unprecedented tumour clearance while preserving immune function. A whole new class: chemo-immunotherapy XXX. 4/4 #AVCT $MRK"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 3690 engagements
"@Jenkoool Huge amounts of money around for preclinical assets. Which is why I keep leaning towards a buyout sooner rather than later. Ample opportunity to sign multiple deals"
X Link @tom_the_bomb__ 2025-10-15T18:38Z 3305 followers, XXX engagements
"Eli Lilly: Leapfrog the ADC incumbents by pairing preCISION-exatecan with our bispecifics radiopharma & IO assets. Precision chemo without the ADC baggage = faster cleaner cheaper. 3/4 #AVCT $LLY"
X Link @tom_the_bomb__ 2025-10-09T09:40Z 3305 followers, 2777 engagements